A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder

Peer Review reports

Original Submission
21 Aug 2022	Submitted	Original manuscript
2 Sep 2022	Reviewed	Reviewer Report - Kirsty Loudon
10 Sep 2022	Author responded	Author comments - Julia Plank
Resubmission - Version 2
10 Sep 2022	Submitted	Manuscript version 2
Publishing
13 Sep 2022	Editorially accepted
30 Sep 2022	Article published	10.1186/s13063-022-06738-3

Back to article page